Northwestern Mutual Wealth Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62K	Buy	1,657 +1,550	+1,449%	+$1.79K	﹤0.01%	3698
2026 Q1	$106	Hold	107	–	–	﹤0.01%	3992
2025 Q4	$146	Hold	107	–	–	﹤0.01%	3823
2025 Q3	$171	Hold	107	–	–	﹤0.01%	3697
2025 Q2	$150	Hold	107	–	–	﹤0.01%	3531
2025 Q1	$172	Hold	107	–	–	﹤0.01%	3465
2024 Q4	$135	Hold	107	–	–	﹤0.01%	3470
2024 Q3	$201	Hold	107	–	–	﹤0.01%	3442
2024 Q2	$792	Hold	107	–	–	﹤0.01%	3237
2024 Q1	$838	Hold	107	–	–	﹤0.01%	3215
2023 Q4	$544	Hold	107	–	–	﹤0.01%	3266
2023 Q3	$633	Hold	107	–	–	﹤0.01%	3098
2023 Q2	$794	Hold	107	–	–	﹤0.01%	3120
2023 Q1	$1.01K	Hold	107	–	–	﹤0.01%	3026
2022 Q4	$1.14K	Hold	107	–	–	﹤0.01%	3031
2022 Q3	$1K	Hold	107	–	–	﹤0.01%	2950
2022 Q2	$1K	Hold	107	–	–	﹤0.01%	2995
2022 Q1	$1K	Hold	107	–	–	﹤0.01%	2964
2021 Q4	$1K	Hold	107	–	–	﹤0.01%	2997
2021 Q3	$1K	Hold	107	–	–	﹤0.01%	2894
2021 Q2	$1K	Hold	107	–	–	﹤0.01%	2861
2021 Q1	$1K	Hold	107	–	–	﹤0.01%	2660
2020 Q4	$1K	Hold	107	–	–	﹤0.01%	2589
2020 Q3	$1K	Sell	107 -1	-0.9%	-$11	﹤0.01%	2419
2020 Q2	$1K	Hold	108	–	–	﹤0.01%	2267
2020 Q1	$1K	Hold	108	–	–	﹤0.01%	2351
2019 Q4	$1K	Hold	108	–	–	﹤0.01%	2270
2019 Q3	$1K	Hold	108	–	–	﹤0.01%	2325
2019 Q2	$1K	Hold	108	–	–	﹤0.01%	2391
2019 Q1	$2K	Hold	108	–	–	﹤0.01%	2290
2018 Q4	$1K	Hold	108	–	–	﹤0.01%	2255
2018 Q3	$2K	Buy	+108	New	+$2.2K	﹤0.01%	2257

Other funds holding ATNM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Compass Financial Management Tampa, Florida $829M AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northwestern Mutual Wealth Management's ATNM Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Actinium Pharmaceuticals (ATNM) stake by 1,449% in Q2 2026, buying an estimated $1.79K and bringing the position to 1,657 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3698.

Northwestern Mutual Wealth Management first reported a position in ATNM in Q3 2018 and has held it in 32 quarters since. The position peaked at $2K in Q1 2019. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

Northwestern Mutual Wealth Management held 1,657 shares of Actinium Pharmaceuticals worth $1.62K as of Q2 2026.
Northwestern Mutual Wealth Management bought 1,550 Actinium Pharmaceuticals shares in Q2 2026, an estimated $1.79K.
Actinium Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3698 holding.
Northwestern Mutual Wealth Management first reported a position in Actinium Pharmaceuticals in Q3 2018 and has held it in 32 quarters since.
Northwestern Mutual Wealth Management's Actinium Pharmaceuticals position peaked at $2K in Q1 2019.
47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.